Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Comparison of Two Medications Aimed at Slowing Aortic Root Enlargement in Individuals With Marfan Syndrome

ClinicalTrials.gov ID: NCT00429364

Public ClinicalTrials.gov record NCT00429364. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 8:20 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Trial of Beta Blocker Therapy (Atenolol) Versus Angiotensin II Receptor Blocker Therapy (Losartan) in Individuals With Marfan Syndrome (A Trial Conducted by the Pediatric Heart Network)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Marfan syndrome is a hereditary connective tissue disorder. Many individuals with this condition die because of the associated heart and blood vessel abnormalities. This study will compare the effectiveness of two medications, losartan and atenolol, at slowing aortic root enlargement in individuals with Marfan syndrome.

Study identification

NCT ID
NCT00429364
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Carelon Research
Other
Enrollment
608 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
6 Months to 25 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2006
Primary completion
Jan 31, 2014
Completion
Jan 31, 2014
Last update posted
Mar 6, 2025

2007 – 2014

United States locations

U.S. sites
24
U.S. states
15
U.S. cities
21
Facility City State ZIP Site status
Cedars-Sinai Medical Center Los Angeles California 90048
Lucile Packard Children's Hospital Palo Alto California 94304
Rady Children's Hospital / UCSD San Diego California 92123
Stanford University School of Medicine Stanford California 94305
Children's Memorial Hospital Chicago Illinois 60614
Johns Hopkins University School of Medicine Baltimore Maryland 21205
Children's Hospital Boston Boston Massachusetts 02115
Children's Hospital of Minnesota - St. Paul Saint Paul Minnesota 55102
Washington University School of Medicine St Louis Missouri 63110
Weill Medical College of Cornell University New York New York 10021
Mount Sinai Medical Center New York New York 10029
Columbia College of Physicians and Surgeons New York New York 10032
Duke University Medical Center Durham North Carolina 27710
Brody School of Medicine at East Carolina University Greenville North Carolina 27834
Wake Forest University Baptist Medical Center Winston-Salem North Carolina 27157
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104
Hospital of the University of Pennsylvania Philadelphia Pennsylvania 19104
Children's Hospital of Pittsburgh Pittsburgh Pennsylvania 15213
Medical University of South Carolina Charleston South Carolina 29425
Vanderbilt University Medical Center Nashville Tennessee 37212
Texas Children's Hospital Houston Texas 77030
Primary Children's Medical Center Salt Lake City Utah 84113
Seattle Children's Hospital Seattle Washington 98105

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00429364, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 6, 2025 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00429364 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →